SCHEMBL7377175

SCHEMBL7377175

[CH2]C(CC(N)=O)c1cc(C)nc(C)c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
ALDH1A1 P00352 3/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP1A2 P05177 1/20 0.33
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
GAA P10253 1/20 0.31
IKBKB O14920 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7379834 0.81 CYP2C19 (0.37) HTTALDH1A1TSHRL3MBTL1CYP2C19
SCHEMBL7380886 0.74 TPMT (0.34) ALDH1A1CYP2C19CYP1A2KDM4ELMNA
SCHEMBL7417348 0.74 EPHX1 (0.33) KMT2AMEN1L3MBTL1CYP2C19
SCHEMBL7562318 0.74 PARP1 (0.46) L3MBTL1CYP2C19GAA
SCHEMBL7411776 0.73 CYP1A2 (0.41) ALDH1A1KMT2AMEN1L3MBTL1CYP2C19
SCHEMBL7380161 0.71 TNF (0.39) HTTTSHRL3MBTL1CYP2C19KDM4E
SCHEMBL7385340 0.70 KDM4E (0.39) ALDH1A1KMT2AL3MBTL1CYP2C19CYP1A2
SCHEMBL7386503 0.70 CES2 (0.41) ALDH1A1GAA
SCHEMBL7382377 0.68 SIRT3 (0.33) HTT
SCHEMBL7414697 0.68 HTT (0.31) HTTKMT2AMEN1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed